Patient-Centered Care in Cystic Fibrosis

Slides:



Advertisements
Similar presentations
Standard 3 Plan and Manage Care NCQA Recognition for Patient-Centered Medical Home 2011 Standards © Qualidigm.
Advertisements

Learn how we are creating our new fully integrated electronic medical record (EMR) to transform the way we deliver patient care. Booth # 1.
Maximizing the role of a pharmacist in your practice
California’s SB 493 Joanne Spetz, PhD Healthforce Center
of Key population living with HIV to HIV Treatment.
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
PeArLS (Personally Arranged Learning Session)
16 Personal Health Records.
Health Strategies Group
Optimizing Statin Therapy
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Managing Women Living With HIV Infection
Management of Mild to Moderate Asthma
What Comes Second?.
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Optimizing Outcomes in the Management of GIST
Organizational Culture in the Oncology Medical Home
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Advances in Cystic Fibrosis Views and Perspectives From Basel, Switzerland, 2016.
Maximizing the role of a pharmacist in your practice
HBV Care Models: Community Collaborations for Best Practices
Introduction. Family Planning and Pregnancy Management in Patients With Chronic Inflammatory Rheumatic Diseases.
Treating HFrEF: Challenges Faced
Talking to Patients About Diabetes Management
Advances in Cystic Fibrosis Perspectives From Orlando, 2016
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Are We Closer to Personalized Medicine in MS?
Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Evaluating Effects of CFTR Modulation in Cystic Fibrosis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Consensus on Glaucoma Control
Managing Depression is a Team Effort:
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors
Poor Response to Initial Therapy for Migraine
The Importance of Getting the Dose Right in HF
Innovations in Home Care
Tools to Address Adherence Issues in Patients With SIHD
What Is Bipolar Disorder?
Management of Systematic Lupus Erythematosus
Program Goals Overview Is NEDA a Reasonable Target?
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
CLINICAL INFORMATION SYSTEM
David N. Sheppard  Journal of Cystic Fibrosis 
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Addressing Treatment Challenges in Cystic Fibrosis
Health Information Systems: Functional Capacity
Improving Effective Basal Insulin Use in Clinical Practice
Improving Adherence to Antiplatelet Therapy After an ACS Event
Development of a Direct Oral Anticoagulant Monitoring Service in a Family Medicine Clinic Caprisse Honsbruch, Leah Mouw, Zachary Mulford, Jay Tieri, Sara.
Clinical Challenges and Updates in Managing Seizure Clusters
Assessing the Burden of Hyperkalemia
Lipid Updates From Spring 2019
Program Goals Overview Is NEDA a Reasonable Target?
Strategies for Infection Control in Cystic Fibrosis
Issues in Patients With Severe Epilepsy
Assessing the Burden of Hyperkalemia
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting.
Ask the Psoriasis Expert
Adherence Learning Lab: Community Conference Pre-Work
Best Practices in Building HIV Care Networks
Presentation transcript:

Patient-Centered Care in Cystic Fibrosis

The Cystic Fibrosis Foundation Recommendations

Communication Is Key to Optimal Patient Care

Challenge of Drug-Drug Interactions

Common Drug-Drug Interactions in the Patients With Cystic Fibrosis

Ivacaftor Drug-Drug Interactions

Lumacaftor/Ivacaftor Drug-Drug Interactions

Lumacaftor/Ivacaftor Drug-Drug Interactions (cont)

Why Isn't My Patient Getting Better? The Challenge of Adherence

Addressing Barriers to Adherence Medication-Based Concerns

Addressing Barriers to Adherence Beyond Medication Obstacles

During the Patient Visit: What to Discuss

When a Drug-Drug Interaction Is Identified

Drug-Drug Interactions With Hormonal Contraceptives

Use of the Electronic Medical Record Within the Clinic

Use of EMR Electronic Medical Record By the Pharmacy

Emerging Therapies: Tezacaftor/Ivacaftor

Abbreviations